Literature DB >> 28034863

Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 1988;72(2):567-572.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28034863     DOI： 10.1182/blood-2016-11-750182

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Arsenic trioxide therapy in relapsed or refractory Japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies.

Authors:  Kazuyuki Shigeno; Kensuke Naito; Naohi Sahara; Miki Kobayashi; Satoki Nakamura; Sinya Fujisawa; Kaori Shinjo; Akihiro Takeshita; Ryuzo Ohno; Kazunori Ohnishi
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

Review 2.  Tumor reversion: a dream or a reality.

Authors:  Avantika Tripathi; Anjali Kashyap; Greesham Tripathi; Joni Yadav; Rakhi Bibban; Nikita Aggarwal; Kulbhushan Thakur; Arun Chhokar; Mohit Jadli; Ashok Kumar Sah; Yeshvandra Verma; Hatem Zayed; Amjad Husain; Alok Chandra Bharti; Manoj Kumar Kashyap
Journal:  Biomark Res       Date:  2021-05-06

3.  Drug-perturbation-based stratification of blood cancer.

Authors:  Sascha Dietrich; Małgorzata Oleś; Junyan Lu; Leopold Sellner; Simon Anders; Britta Velten; Bian Wu; Jennifer Hüllein; Michelle da Silva Liberio; Tatjana Walther; Lena Wagner; Sophie Rabe; Sonja Ghidelli-Disse; Marcus Bantscheff; Andrzej K Oleś; Mikołaj Słabicki; Andreas Mock; Christopher C Oakes; Shihui Wang; Sina Oppermann; Marina Lukas; Vladislav Kim; Martin Sill; Axel Benner; Anna Jauch; Lesley Ann Sutton; Emma Young; Richard Rosenquist; Xiyang Liu; Alexander Jethwa; Kwang Seok Lee; Joe Lewis; Kerstin Putzker; Christoph Lutz; Davide Rossi; Andriy Mokhir; Thomas Oellerich; Katja Zirlik; Marco Herling; Florence Nguyen-Khac; Christoph Plass; Emma Andersson; Satu Mustjoki; Christof von Kalle; Anthony D Ho; Manfred Hensel; Jan Dürig; Ingo Ringshausen; Marc Zapatka; Wolfgang Huber; Thorsten Zenz
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

4.  Realgar (As4S4), a traditional Chinese medicine, induces acute promyelocytic leukemia cell death via the Bcl-2/Bax/Cyt-C/AIF signaling pathway in vitro.

Authors:  Zonghong Li; Ruiming Zhang; Xuewei Yin; Nana Li; Siyuan Cui; Teng Wang; Xing Tan; Mingyue Shen; Yun Guo; Jinxin Wang; Dadong Guo; Ruirong Xu
Journal:  Aging (Albany NY)       Date:  2022-09-12       Impact factor: 5.955

Review 5.  Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era.

Authors:  Zheng-Li Xu; Xiao-Jun Huang
Journal:  Front Oncol       Date:  2020-10-20       Impact factor: 6.244
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.